Related Experiment Video
Updated: May 16, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
[Preventive treatment of prolongation of the QT interval]
Jarosław Szponar1, Karolina Zapalska-Pozarowska, Elzbieta Szponar
1Samodzielny Publiczny Szpital Wojewódzki im. Jana Bozego w Lublinie, Regionalny Ośrodek Toksykologii Klinicznej. szponar.jarek@gmail.com
Insights
Prolongation of the QT interval, a measure of heart rhythm, indicates poor prognosis in various heart conditions. Understanding its causes and accurate measurement is crucial for managing long QT syndrome and preventing adverse outcomes.
Area of Science:
- Cardiology
- Clinical Electrophysiology
Context:
- QT interval prolongation is a significant predictor of adverse cardiac events across diverse patient populations, including those with and without pre-existing heart disease.
- It is observed in numerous medical conditions and can manifest as a congenital or acquired electrocardiogram (ECG) anomaly.
- The prolonged QT interval is the hallmark symptom of long QT syndrome (LQTS).
Purpose:
- To elucidate the clinical significance of the QT interval in electrocardiography.
- To outline standardized measurement rules and address challenges in accurately assessing QT/QTc intervals.
- To discuss the etiologies of QT interval prolongation, encompassing congenital and acquired forms of long QT syndrome, and to review management strategies.
Summary:
- This review details the prognostic implications of QT interval prolongation in cardiology.
- It covers the diagnostic criteria, measurement techniques, and common causes of prolonged QT intervals.
- The paper also addresses the management of patients with QT prolongation and preventative measures for iatrogenic LQTS.
Impact:
- Improved understanding of QT interval prolongation aids in risk stratification and patient management.
- Accurate ECG interpretation can lead to earlier diagnosis and intervention for long QT syndrome.
- Knowledge of iatrogenic causes facilitates the prevention of drug-induced QT prolongation and associated arrhythmias.
Abstract:
Prolongation of QT interval is an indicator of bad prognosis in general population of people with heart disease, in patients after myocardial infarction and in people without recognized heart disease. Prolongation of QT interval occurs in many diseases and clinical states. It may be congenital or acquired ECG anomaly and it determines the basic symptom of long QT syndrome. In this paper we present clinical meaning of QT interval, measurement rules and problems with correct valuation of QT/QTc in electrocardiogram. We also discuss reasons of QT interval prolongation--congenital or acquired long QT syndrome, as well as the procedure in case of QT interval prolongation and possibilities of preventive treatment of iatrogenic long QT syndrome.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
